Aug 18, 2022KRTL Holding Group Inc Welcomes Dr. Malcolm A. Leissring as Chief Science Officer of KRTL BiotechKRTL Holding Group, Inc. (OTC: KRTL) is pleased to announce its wholly owned subsidiary, KRTL Biotech, Inc., an international research, and development company, has appointed Dr. Malcolm A. Leissring as its founding Chief Science Officer. "I am honored to be a part of this vibrant team of experts with such complementary expertise. The future indeed looks very bright for us," said Dr. Leissring.
KRTL Holding Group, Inc. (OTC: KRTL) is pleased to announce its wholly owned subsidiary, KRTL Biotech, Inc., an international research, and development company, has appointed Dr. Malcolm A. Leissring as its founding Chief Science Officer. "I am honored to be a part of this vibrant team of experts with such complementary expertise. The future indeed looks very bright for us," said Dr. Leissring.
